ACHL

ACHL


A Step in the Right Direction: Updates for Your PAD Patients Post-Revascularization

For your patients with PAD post-revascularization, what can you do to ensure the next “steps in the right direction”? In this activity, expert faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. Roundtable discussion is included to provide practical insight for clinicians to apply knowledge to their practice.
ACHL

Advances in the Use of Checkpoint Inhibitors in the Treatment of Esophageal Cancer

Finally, after many years, esophageal cancer (EC) care is undergoing an evolution. Clinicians need to learn about the novel immunotherapies that have only recently been approved for EC. In this 24-minute video interview, Dr. Ashiq Masood, Director of Gastrointestinal Medical Oncology at Rush University Medical Center in Chicago, IL interviews Dr. Manish Shah Director of Gastrointestinal Oncology...
ACHL

Applying Institutional Susceptibility Data in Treatment Decisions for HAP/VAP

Are you an infectious disease (ID) pharmacist? Want to learn more about hospital- and ventilator-associated pneumonia (HAP/VAP) due to P. aeruginosa? This webcast is for you! Developed in collaboration with Making a Difference in Infectious Disease (MAD-ID), expert ID pharmacists Jim Lewis and Jason Pogue discuss the latest strategies to treat HAP/VAP and mitigate antibiotic resistance. This...
ACHL

Are PAH-targeted Therapies Beneficial for CTD-PAH?

In this video-based activity, Dr. Victor Tapson shares the importance of therapy selection for patients with pulmonary arterial hypertension associated with connective tissue disease. Providing real-world insight and key takeaways for application to clinical practice, Dr. Tapson discusses which PAH therapies are beneficial for patients with CTD-PAH and the importance of a multidisciplinary team ...
Purdue University College of Pharmacy

Are We There Yet? Strategies to Employ JAK Inhibitors in T2T for RA

Are you effectively employing treat-to-target strategies into your daily practice? Data from the Corrona RA registry tell a different story: a large number of patients with RA still had moderate or high levels of disease activity after 6 and 12 months of csDMARD and/or bDMARD therapy, with no acceleration of treatment. Dr. Allan Gibofsky, Co-Director, Clinic for Inflammatory Arthritis and Biolog...
ACHL

Breakthroughs for Obese Patients with VTE

What is the latest evidence for VTE prophylaxis and treatment in obese patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention and management. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice.
ACHL

Chart Your Path in the Management of AML: Guidance from MD Anderson Expert Faculty

This enhanced digital algorithm combines stepwise practical guidance with evidence-based educational context to deliver an immersive learning opportunity for clinicians who strive to provide their patients with Acute Myeloid Leukemia (AML) the best possible care. The ‘choose your path’ environment allows clinicians to select a clinical area of their interest and navigate AML management based...
ACHL

Closing in on Post-Thrombotic Syndrome: The Latest Updates

Dr. Kush Desai from Northwestern Medicine and Dr. Erin Murphy from Sanger Heart and Vascular, Atrium Health discuss the latest updates in post-thrombotic syndrome (PTS) including a review on the newer venous stents as well as limitations with conservative therapies in this targeted 30-minute CME eNewsletter. The touchpoint also features images, easy-to-read charts and graphs and feature their ex...
ACHL

Complex Psoriasis Patients and Challenging Areas to Treat

Areas of plaque psoriasis that are particularly challenging to treat are more common than previously thought, and these areas may not respond as well to traditional treatment approaches. Moreover, they are associated with lower patient quality of life. Clinicians can provide valuable patient-centered care for these psoriasis manifestations by facilitating discussions about treatment goals and fo...
ACHL

COVID-19 and Rheumatology Care: How Does it Impact My Patients?

Already facing unprecedented changes in approaches to patient care, rheumatology practices must now navigate the unfamiliar landscape of COVID-19 and translate rapidly evolving evidence into routine clinical practice. And while every day brings new data and guidance on best practices for managing rheumatology patients during a pandemic, it is often the perspectives of our colleagues in the field...
ACHL

Deciphering Rare irAEs: A Go-to-Guide

This immersive CME infographic will provide a stepwise visual to support improved recognition and management of rare immune-related adverse events (irAEs) for patients on immune checkpoint inhibitors (ICPIs). The infographic will synthesize and visualize data, guidelines and decision-making recommendations, as well as imbed faculty commentaries that offer “how-to” methods for introducing str...
ACHL

Decisions in Interventional Management of Acute Pulmonary Embolism

Clinicians who diagnose and treat patients with acute pulmonary embolism (PE) need to be updated on guidelines and trials regarding the current interventional therapeutic landscape, particularly with catheter-directed devices. In this targeted 30-minute CME touchpoint, Dr. Adrian Messerli from UK HealthCare discusses the latest recommendations for the management of PE. This interactive activity...
ACHL

Delivering Appropriate Nutrition for the Critically Ill Adult

Symposium highlights held in conjunction with the ASPEN 2020 Nutrition Science & Practice Conference! Have you ever wondered what your patients want you to know about their clinical nutrition? Join us and listen to an expert panel that will discuss two patient cases relating to the assessment and selection of nutritional support for hospitalized patients, including a discussion of newly av...
ACHL

Final Chapter: Post-COVID-19 Fibrosis and the Role of Antifibrotic Therapy Management

What do we know about post-ARDS fibrosis in patients who have recovered from COVID-19? In this 8-minute CME-certified vlog, leading pulmonology expert Christopher King, MD, FACP, FCCP, Director of Transplant and Advanced Lung Disease Critical Care Program at Inova Fairfax Hospital, will discuss topics such as: • post-ARDS fibrosis in patients who have recovered from COVID-19 • the potentia...
ACHL

Hindsight is 2020: COVID-19 and Cancer Care

As the global COVID-19 pandemic enters its second year, advances in preventive measures and treatment approaches are now benefiting patients dealing with cancer. In turn, clinicians, cancer patients, and clinical practice have evolved to continue life-saving treatment. Mia Levy, MD, PhD, System Vice President for Cancer Services at Rush System for Health, leads a discussion with Rush Universi...
ACHL

Improving Clinical Outcomes Through PARP Inhibition in Patients with Advanced Ovarian Cancer

This digital algorithm offers stepwise practical guidance to prepare oncologists to employ PARP inhibitors effectively and safely in eligible ovarian cancer patients. Due to the many patient characteristics that determine eligibility, the algorithm supports branching logic in the context of patient disease status, response to chemotherapy, molecular profile, and tolerability. This activity is...
Rush University Medical Center

Improving Outcomes in CTD-PAH: Diagnosis, Treatment & Multidisciplinary Care

In this interview-style eNewsletter, Dr. Dinesh Khanna and Dr. Victor Tapson share ways to improve the recognition and diagnosis of CTD-PAH. Through discussions on the role of screening and a review of current and emerging therapies, our faculty provide context to creating a personalized treatment approach that highlights the importance of increasing communication across a multidisciplinary team...
Purdue University College of Pharmacy

In Limb-O: Improving CAD and PAD Care in the Stably Unstable

Unprotected, your patients with CAD and PAD are on the edge, in “limb-o” – how do we get them to become more in balance? In this activity, expert multidisciplinary faculty cover the latest guideline recommendations and clinical trial data related to managing patients with PAD post-revascularization. A patient case is woven throughout this discussion to increase opportunities for clinicians...
ACHL

Maximizing Current Therapies and Exploring Future Directions as PARP Inhibitors Take the Stage in Prostate Cancer

This curriculum features expert commentaries and case discussions that synthesize data around PARP inhibition and its evolving place in the treatment of patients with prostate cancer. Faculty provide practical guidance to apply available and emerging data in real-world decision-making that clinicians are faced with on a daily basis including: interpreting results to inform treatment decisions, b...
ACHL

Multidisciplinary Team Strategies for Managing Tardive Dyskinesia

Dive into this engaging, digital newsletter created by our multidisciplinary faculty panel, Christoph Correll, MD and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC to learn proper recognition and management of tardive dyskinesia (TD). This newsletter includes guidance on diagnostic criteria, treatment algorithms, as well as strategies with how to incorporate novel therapies while ensuring optimal adhe...
ACHL

Needs Across the Patient Continuum: The Intersection of Energy and Protein

Symposium highlights held in conjunction with the ASPEN 2020 Nutrition Science and Practice Conference. The nutritional needs of critically ill patients during hospitalization and after discharge are complex, and the importance of assessing energy expenditure and tailoring nutritional therapies to the individual is increasingly apparent. Although a great deal of study is still needed, accumul...
ACHL

New Horizons in Migraine Prevention: Pathways to Personalized Care with CGRPs

Join an expert faculty panel as they discuss the role of new and emerging anti-CGRP mAbs in migraine prevention. This 60-minute video-based highlights activity will integrate didactic presentation with polling questions, as experts review clinical evidence, guideline recommendations, and shared decision-making strategies. Background: Migraines represent a common, debilitating disorder that c...
ACHL

New Horizons in Migraine Prevention: Pathways to Personalized Care with CGRPs—the Year in Review

Join an expert faculty panel as they discuss incorporating anti-CGRP monoclonal antibodies into daily clinical practice for migraine prevention. This video-based session will integrate didactic presentation, a case-based panel discussion, and expert review of clinical evidence, guideline recommendations, special considerations, and real-world use. Migraines represent a common, debilitating di...
ACHL

Optimizing Medical Management Post-Revascularization: A Case Review

In this activity, expert faculty give their multidisciplinary perspectives in vascular surgery and cardiology regarding recommendations for patients with peripheral artery disease (PAD) post-revascularization. These patients are at risk for further complications and may be eligible for additional therapy. Dr. Marc Bonaca and Dr. Alan Dietzek relay practice implications of the latest guidelines a...
ACHL

Practical Approaches to Diagnosis and Treatment of CF-ILD

This web-based multi-faceted digital flipbook addresses the latest diagnostic and treatment strategies for patients with CF-ILD. To improve knowledge retention and recall, text-based education is enhanced through video and audio snippets from a leading pulmonology expert, on how to optimize diagnosis, treatment, monitoring, and multidisciplinary collaboration. Videos, charts, and sound bytes wil...
ACHL

Prevent the Downward Spiral: Restoring the Gut Microbiota to Reduce Recurrent C. difficile Infection

Are we waiting too long? It’s time to get off this ride to avoid the downward spiral of recurrent C. difficile. Paul Feuerstadt, MD, Teena Chopra, MD and Kevin Garey, PharmD, discuss the gut microbiota role, management of C. difficile infection in special populations, safety and efficacy of fecal microbiota transplantation, and emerging microbiota restoration therapies.
ACHL

Revolutionizing T2T in RA: Future Paradigms with JAK Inhibitors

How can clinicians be assured they have the most up-to-date information for improving their patients’ outcomes in RA care? In this clinical commentary, leading infectious disease expert Kevin Winthrop, MD, MPH, and Rheumatology experts Philip Mease, MD, MACR, and William F.C. Rigby, MD, discuss the latest evidence, safety data, and potential roles with the available and emerging JAK inhibitors...
ACHL

Sparing and Restoring the Gut Microbiota: A Faculty Review of Recent Abstracts and Literature in C. difficile

Don’t have time to sift through all the literature and data recently published on C. difficile? Dr. Paul Feuerstadt provides a concise and practical review of the literature including the changing epidemiology, and the safety and efficacy of fecal microbiota transplantation
ACHL

Sparing and Restoring the Gut Microbiota: Clinical Case Challenges: Treatment of C. difficile Infection

Dr. Sahil Khanna and Dr. Kevin Garey use a case-based approach to walk participants through the selection of therapy for two patients with C. difficile infection. Discussion topics include risk factors, triaging severity of infection, and guideline-recommended therapies. Clinical decision points throughout the activity allow learners to test their skills in managing patients with C. difficile,...
ACHL

Sparing and Restoring the Gut Microbiota: Non-Antimicrobial Approaches for Recurrent C. difficile: What’s New on the Horizon ?

Dr. Paul Feuerstadt introduces the concept of non-antimicrobial therapies for treatment of C. difficile infection and prevention of recurrence. Discussion focuses on the efficacy of available monoclonal antibodies and available and emerging microbiota replacement therapies
ACHL

Straight Talk with the Expert Surrounding COVID-19 and Your Patients with ILD

Dr. Imre Noth summarizes what we have learned through August 2020 about COVID-19 and its implications for patients with interstitial lung disease (ILD) while providing his own front-line clinical experiences. Talking points include mitigating risks of COVID-19 in patients with ILD, strategies to help patients continue ILD treatment and supportive care, as well as strategies to differentiate post...
ACHL

Tales from the Trenches: COVID-19’s Impact on Cancer Care

The unprecedented era that healthcare providers around the world are facing given the COVID-19 pandemic leaves countless unanswered questions, forcing clinicians and cancer patients to adapt to the current environment. How can clinicians be assured they stay apprised of rapidly evolving data during COVID-19 and consider implications to cancer care? Mia Levy, MD, PhD, System Vice President for...
ACHL

The C. diff Returns: The Latest Strategies to Mitigate Recurrence.

Originally presented at a virtual symposium following the IDWeek™ 2020, Paul Feuerstadt, MD, Kevin W. Garey, PharmD, and Krishna Rao, MD, discuss guideline-directed prevention and treatment of recurrent Clostridium difficile (C. diff). Other discussion topics include risk factors for C. diff recurrence as well as antimicrobial interventions to reduce recurrence and improve outcomes.
ACHL

The Emerging Role of the Gut Microbiome in Reducing Recurrence of C. difficile Infection

In this activity, internal medicine and gastroenterology faculty discuss community- and healthcare-associated C. difficile infection, the increasing incidence of recurrent infection, therapy selection, and when to refer to a specialist. The video-based format, with supporting slides and multidisciplinary panel discussions, provides a comprehensive perspective on the challenges faced by clinician...
ACHL

The Next Chapter: Post-Care After COVID-19 Recovery

What are the recommended follow-up and post-care strategies for patients who have recovered from COVID-19? In this concise 15-minute CME-certified vlog, hear from leading Pulmonology expert, Imre Noth, MD, Chief of Pulmonary & Critical Care Medicine from the University of Virginia School of Medicine who will discuss long-term post-COVID-19 monitoring strategies. Learn the latest guidance and cli...
ACHL

The Unfinished Chapter: Does COVID-19 Cause Progressive Fibrosis?

Can you distinguish fibrosis secondary to ARDS/acute lung injury from that of ILD? This 15-minute CME-certified vlog, featuring leading pulmonology expert, Christopher King, MD, FACP, FCCP as well as radiologist Melany Atkins, MD, will break down the key differences. Discussion will also include: • Radiologic case findings from a patient who has developed fibrosis secondary to COVID-19 infect...
ACHL

Understanding the Importance of Screening CTD Patients for PAH

In this video-based activity, Dr. Dinesh Khanna shares the importance of screening patients with connective tissue disease for pulmonary arterial hypertension to facilitate earlier diagnosis and improve patient outcomes. Dr. Khanna discusses the impact of delayed diagnosis, screening protocols, barriers to physician adherence, and the importance of a multidisciplinary team. A patient case offers...
Purdue University College of Pharmacy

VTE Prophylaxis in Acutely Ill Medical Patients

What is the latest evidence for VTE prophylaxis in acutely ill medical patients and how is this different from the current guidelines? In this activity, expert cardiology faculty cover the most recent data and guideline limitations on VTE prevention in this key patient group. Roundtable discussion is included to provide practical insight to help clinicians apply knowledge to their practice.
ACHL

What the PCP Needs to Know About IPF: From Diagnosis to Referral

In this activity, pulmonologist Gregory Cosgrove, MD, discusses the signs and symptoms of IPF to help PCP learners identify at-risk patients and achieve goals of earlier referral and treatment initiation, ultimately improving patient quality of life. The activity also features an animated whiteboard to illustrate take-home points for the PCP audience. Clinicians require education surrounding ...
ACHL

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map